A single cell atlas of the human liver tumor microenvironment.


Journal

Molecular systems biology
ISSN: 1744-4292
Titre abrégé: Mol Syst Biol
Pays: England
ID NLM: 101235389

Informations de publication

Date de publication:
12 2020
Historique:
received: 01 05 2020
revised: 11 11 2020
accepted: 18 11 2020
entrez: 17 12 2020
pubmed: 18 12 2020
medline: 27 8 2021
Statut: ppublish

Résumé

Malignant cell growth is fueled by interactions between tumor cells and the stromal cells composing the tumor microenvironment. The human liver is a major site of tumors and metastases, but molecular identities and intercellular interactions of different cell types have not been resolved in these pathologies. Here, we apply single cell RNA-sequencing and spatial analysis of malignant and adjacent non-malignant liver tissues from five patients with cholangiocarcinoma or liver metastases. We find that stromal cells exhibit recurring, patient-independent expression programs, and reconstruct a ligand-receptor map that highlights recurring tumor-stroma interactions. By combining transcriptomics of laser-capture microdissected regions, we reconstruct a zonation atlas of hepatocytes in the non-malignant sites and characterize the spatial distribution of each cell type across the tumor microenvironment. Our analysis provides a resource for understanding human liver malignancies and may expose potential points of interventions.

Identifiants

pubmed: 33332768
doi: 10.15252/msb.20209682
pmc: PMC7746227
doi:

Banques de données

GEO
['GSE146409']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e9682

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States

Informations de copyright

© 2020 The Authors. Published under the terms of the CC BY 4.0 license.

Références

Cell. 2020 Oct 15;183(2):377-394.e21
pubmed: 32976798
Oncogenesis. 2019 Jan 25;8(2):9
pubmed: 30683932
Nature. 2013 Sep 19;501(7467):355-64
pubmed: 24048068
Nature. 2019 Oct;574(7778):365-371
pubmed: 31597962
Nat Commun. 2020 Apr 22;11(1):1936
pubmed: 32321913
Cell Rep. 2017 May 30;19(9):1902-1916
pubmed: 28564607
J Clin Invest. 2013 Jan;123(1):418-31
pubmed: 23241958
Nat Commun. 2015 Jul 22;6:7866
pubmed: 26198319
Elife. 2017 Dec 05;6:
pubmed: 29206104
FEBS J. 2018 Feb;285(4):734-751
pubmed: 29106767
Curr Opin Biotechnol. 2017 Aug;46:126-133
pubmed: 28346891
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Hepatology. 2004 Oct;40(4):925-32
pubmed: 15382127
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
J Hepatol. 2020 Nov;73(5):1118-1130
pubmed: 32505533
Nat Methods. 2020 Feb;17(2):159-162
pubmed: 31819264
Nat Cell Biol. 2017 Aug;19(8):915-927
pubmed: 28714968
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
NPJ Breast Cancer. 2018 Apr 30;4:9
pubmed: 29736411
Nat Methods. 2014 Apr;11(4):417-22
pubmed: 24584193
Nature. 2017 Jun 22;546(7659):533-538
pubmed: 28614297
Nat Genet. 2012 May 06;44(6):694-8
pubmed: 22561517
Cell Metab. 2019 Jul 2;30(1):201-211.e6
pubmed: 31056286
Nat Metab. 2019 Sep;1(9):899-911
pubmed: 31535084
Cell. 2018 Nov 1;175(4):1156-1167.e15
pubmed: 30270040
Sci Rep. 2017 Aug 18;7(1):8815
pubmed: 28821810
Trends Genet. 2009 Jan;25(1):30-8
pubmed: 19054589
Cell. 2019 Oct 31;179(4):829-845.e20
pubmed: 31675496
Gastroenterology. 2013 Apr;144(4):829-40
pubmed: 23295441
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Front Immunol. 2017 Dec 19;8:1830
pubmed: 29312327
Dev Cell. 2008 Jul;15(1):23-36
pubmed: 18606138
Nature. 2019 Nov;575(7783):512-518
pubmed: 31597160
Nat Med. 2014 Apr;20(4):436-42
pubmed: 24584119
Exp Mol Med. 2017 Dec 15;49(12):e413
pubmed: 29244788
J Cell Biol. 2009 May 18;185(4):743-54
pubmed: 19433454
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
Nat Biotechnol. 2020 Jun;38(6):747-755
pubmed: 32518403
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Dev Cell. 2011 Aug 16;21(2):193-215
pubmed: 21839917
Nat Biotechnol. 2018 Nov;36(10):962-970
pubmed: 30222169
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nature. 2017 Feb 16;542(7641):352-356
pubmed: 28166538
Nat Commun. 2018 Jul 26;9(1):2937
pubmed: 30050112
Am J Clin Pathol. 2012 Aug;138(2):211-22
pubmed: 22904132
Mol Cancer Ther. 2009 Aug;8(8):2103-9
pubmed: 19671746
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Science. 2017 Sep 22;357(6357):1299-1303
pubmed: 28798045
Mol Syst Biol. 2020 Dec;16(12):e9682
pubmed: 33332768
Cancer Cell. 2003 Jul;4(1):19-29
pubmed: 12892710
Biochem Soc Trans. 2017 Aug 15;45(4):855-870
pubmed: 28673936
Science. 2014 Feb 14;343(6172):776-9
pubmed: 24531970
Circ Res. 2005 Sep 16;97(6):512-23
pubmed: 16166562
Cell. 2018 Sep 6;174(6):1373-1387.e19
pubmed: 30193111
Mol Cell. 2015 Apr 2;58(1):147-56
pubmed: 25728770
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):189-200
pubmed: 21460876
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Nat Med. 2015 Aug;21(8):846-53
pubmed: 26248267
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Cell Tissue Res. 1992 Dec;270(3):469-74
pubmed: 1283113
Matrix Biol. 2016 Jan;49:10-24
pubmed: 26163349
Immunity. 2020 Sep 15;53(3):641-657.e14
pubmed: 32888418
Nat Cell Biol. 2011 Nov 27;14(1):106-14
pubmed: 22119784
Nat Med. 2018 Aug;24(8):1277-1289
pubmed: 29988129
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
Mol Syst Biol. 2010 Sep 7;6:411
pubmed: 20823849
Cell. 2017 Jun 15;169(7):1342-1356.e16
pubmed: 28622514
Nature. 2019 Aug;572(7768):199-204
pubmed: 31292543
Br J Cancer. 2019 Jan;120(2):218-228
pubmed: 30559346
Nat Rev Cancer. 2012 Apr 19;12(5):323-34
pubmed: 22513401
Nat Rev Dis Primers. 2016 Apr 14;2:16018
pubmed: 27158749
Am J Hematol. 2010 Aug;85(8):593-8
pubmed: 20540157
Nat Rev Gastroenterol Hepatol. 2019 Jul;16(7):395-410
pubmed: 30936469
Science. 2002 Oct 25;298(5594):824-7
pubmed: 12399590
Nat Commun. 2019 Jul 26;10(1):3350
pubmed: 31350390
Gigascience. 2018 Jun 1;7(6):
pubmed: 29846586
Nature. 2013 Sep 19;501(7467):328-37
pubmed: 24048065
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923

Auteurs

Hassan Massalha (H)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Keren Bahar Halpern (K)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Samir Abu-Gazala (S)

Department of General Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Transplant Division, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.

Tamar Jana (T)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Efi E Massasa (EE)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Andreas E Moor (AE)

Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.

Lisa Buchauer (L)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Milena Rozenberg (M)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Eli Pikarsky (E)

The Lautenberg Center for Immunology, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel.

Ido Amit (I)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Gideon Zamir (G)

Department of General Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Shalev Itzkovitz (S)

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH